maintenance_mode

TL3 Regular · Christchurch, NZ

Maintenance dosing, lowest effective dose, and the awkward question of how long is long enough.

Joined 12 October 2024 · last posted 3d

138 posts, newest first. Showing up to 150.

Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #101 · Data & Tools › Datasets · 24 Jul 2026 · 0 likes I have three months of notes on community side-effect dataset and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
How shortages have affected compounding permissions Replied, post #52 · Access › Shortages · 19 Jul 2026 · 23 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful. Adding…
Immortal time bias in a claims-database study — one year on Replied, post #32 · Evidence › Study critique · 19 Jul 2026 · 0 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
Deletion sequences: expected mass shifts by residue — the long version Replied, post #16 · Analytics › Impurities & related substances · 19 Jul 2026 · 31 likes Post #15 is the version of this I will quote in future. One addition. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #67 · Evidence › Journal club · 16 Jul 2026 · 5 likes Fair, and the limits you put on it are the part I will remember.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #107 · Devices › Syringes & needles · 15 Jul 2026 · 10 likes Picking up post #106: that is the part I would want checked first. Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the…
Journal club: what we got wrong in an earlier session Replied, post #81 · Evidence › Journal club · 13 Jul 2026 · 21 likes Post #79 is the version of this I will quote in future. One addition. The baseline characteristics table is the single most useful page for the questions that get asked…
How shortages have affected compounding permissions Replied, post #16 · Access › Shortages · 5 Jul 2026 · 0 likes Everything in post #13 holds. The case it does not cover is the one I have. Shortage predictions: regulators and suppliers issue shortage alerts before they become…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 5 Jul 2026 · 6 likes Adding the boring version of cagrilintide alone, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #98 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 12 likes Carryover is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #39 · Analytics › Impurities & related substances · 1 Jul 2026 · 0 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
Prescription requirements and telehealth models — a second dataset Replied, post #83 · Sourcing › Regulatory · 28 Jun 2026 · 30 likes The number people quote for Prescription requirements and telehealth models is a central estimate presented without its interval, and the interval is wide enough that…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #48 · Compounds › Repair & healing peptides · 25 Jun 2026 · 26 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
About the Receptor biology category Replied, post #6 · Pharmacology › Receptor biology · 24 Jun 2026 · 0 likes Building on post #5 rather than restating it. Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread starts…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #127 · Practice › Reconstitution · 24 Jun 2026 · 0 likes Post #123 and I disagree about the size of the effect, not about the direction. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL…
Submitting a sample: the process end to end Replied, post #35 · Sourcing › Independent verification · 24 Jun 2026 · 16 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. The reasoning is more useful than the number,…
Follow-up: Sleep quality changes during weight loss Replied, post #49 · Wellbeing › Sleep · 20 Jun 2026 · 1 like Nothing here is medical advice, and suspected sleep-disordered breathing specifically is something to have assessed properly rather than tracked.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #11 · Clinical › Bloodwork · 15 Jun 2026 · 1 like Post #9 describes the usual case. This is about the unusual one. Reference intervals are constructed to contain the central ninety-five per cent of a reference…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #23 · Compounds › Secretagogues & GH axis · 14 Jun 2026 · 26 likes This follows post #20 rather than contradicting it. CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very…
Revisiting: What pooling buys you and what it destroys Replied, post #52 · Evidence › Meta-analyses · 12 Jun 2026 · 23 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. Nothing above should…
Racemisation and why it is invisible to a mass measurement Replied, post #40 · Analytics › Impurities & related substances · 10 Jun 2026 · 3 likes What I would tell a new member reading about racemisation for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Historical amylin analogues and what happened to them Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 9 Jun 2026 · 2 likes Worth stating the null on historical amylin analogues before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #26 · Compounds › Secretagogues & GH axis · 7 Jun 2026 · 4 likes That matches what I have seen, for whatever a single anecdote is worth.
Reading a trial's population section before its results Replied, post #83 · Evidence › Trials · 3 Jun 2026 · 0 likes Narrowing post #82, because the general version has more than one answer. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they…
Injecting into an area that has become firm: why not to Replied, post #7 · Practice › Administration · 2 Jun 2026 · 6 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. If you have to inject at a different time of day than usual, that is a much smaller…
The anatomy of a question that gets answered within an hour Replied, post #59 · Start Here › How to Ask · 28 May 2026 · 0 likes Narrowing post #56, because the general version has more than one answer. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #52 · Meta › Announcements · 24 May 2026 · 3 likes An update on my earlier Trust level 3 requirements post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Publication patterns in the BPC-157 literature, examined Started this topic · Compounds › Repair & healing peptides · 20 May 2026 · 3 likes Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. Putting the numbers in…
What a certificate commits its issuer to — the long version Replied, post #8 · Analytics › COA interpretation · 19 May 2026 · 0 likes Everything in post #4 holds. The case it does not cover is the one I have. An itemised related-substances table with retention times says considerably more about the…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #5 · Compounds › Secretagogues & GH axis · 12 May 2026 · 5 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #45 · Sourcing › Independent verification · 10 May 2026 · 1 like On Janoshik I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #35 · Compounds › Tirzepatide · 9 May 2026 · 30 likes I think the Tirzepatide and nausea question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Micro-titration: a disputed topic, argued properly Replied, post #66 · Practice › Dosing & titration · 27 Apr 2026 · 4 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
Second pass at: Why chargeback is not the safety net people assume Replied, post #2 · Sourcing › Payments · 20 Apr 2026 · 16 likes The opening post is right about the mechanism and I think understates the practical bit. Chargeback reality: if you pay by credit card and the supplier does not…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #21 · Clinical › Bloodwork · 13 Apr 2026 · 31 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Choosing which test to pay for, given a fixed budget Replied, post #61 · Sourcing › Independent verification · 9 Apr 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Why the titration planner refuses to produce a schedule below a floor Replied, post #59 · Data & Tools › Calculators · 9 Apr 2026 · 29 likes Titration planner refuses is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #38 · Practice › Administration · 31 Mar 2026 · 27 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #16 · Meta › Announcements · 14 Mar 2026 · 30 likes Following this. I have the same question and no better information than the first post.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #18 · Compounds › Repair & healing peptides · 9 Mar 2026 · 5 likes Whatever the answer on Reading a preclinical wound-healing model turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in…
Waist circumference technique and its repeatability Replied, post #61 · Outcomes › Progress reports · 9 Mar 2026 · 9 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. I have no interest in any supplier named above.
Residual solvents and scavengers: what is looked for — what changed since Replied, post #13 · Analytics › Impurities & related substances · 5 Mar 2026 · 0 likes Post #12 is right about the mechanism and I think understates the practical bit. For anyone finding this later: the short answer on Residual solvents and scavengers is…
Coming back to: Time to steady state after a dose increase Replied, post #8 · Pharmacology › Pharmacokinetics · 2 Mar 2026 · 0 likes Picking up post #5: that is the part I would want checked first. Body weight affects volume of distribution and therefore exposure at a fixed dose. Whether that…
Choosing which test to pay for, given a fixed budget Replied, post #10 · Sourcing › Independent verification · 1 Mar 2026 · 18 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. The disagreement above is…
Coming back to: Swirling versus inverting versus leaving it alone Started this topic · Practice › Reconstitution · 25 Feb 2026 · 18 likes Swirling versus inverting versus leaving it alone Writing it up because I had to work it out twice and would rather nobody else did. Swirling versus inverting versus…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #76 · Outcomes › Progress reports · 17 Feb 2026 · 4 likes Post #74 answers the question as asked. The question underneath it is different. I disagree with the framing of Seven-day rolling above, and I think it is a substantive…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #6 · Meta › Announcements · 17 Feb 2026 · 0 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
The most common factual error about semaglutide on the internet — what changed since Replied, post #25 · Compounds › Semaglutide · 11 Feb 2026 · 24 likes I read post #23 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
Dead volume across syringe and needle combinations Replied, post #69 · Devices › Syringes & needles · 9 Feb 2026 · 7 likes Source for the dead volume across syringe figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #78 · Pharmacology › Pharmacokinetics · 8 Feb 2026 · 17 likes Worth separating two things that post #76 runs together. The confident answers on Half-life and the well-sourced answers are not the same answers, which is the most…
Gastro-oesophageal reflux: improving or worsening? Replied, post #17 · Clinical › Comorbidities · 7 Feb 2026 · 5 likes Post #16 is right about the mechanism and I think understates the practical bit. On gastro-oesophageal reflux I would separate what is worth knowing from what is worth…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #78 · Access › Pricing · 2 Feb 2026 · 1 like Everything in post #75 holds. The case it does not cover is the one I have. The reason Price changes is hard to answer is that the obvious measurement and the relevant…
Coming back to: Solubility limits and what a cloudy solution is telling you Started this topic · Pharmacology › Formulation chemistry · 29 Jan 2026 · 0 likes On the subject in the title: Solubility limits and what a cloudy solution is telling you Working notes rather than a conclusion. Reading back through what has been…
Revisiting: Absolute versus relative contraindications Replied, post #12 · Safety › Contraindications · 22 Jan 2026 · 24 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. On reflection I would soften that…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #57 · Analytics › Method validation · 22 Jan 2026 · 12 likes Worth separating two things that post #55 runs together. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #42 · Clinical › Bloodwork · 2 Jan 2026 · 7 likes Understood. Thank you for being specific about the limits of it.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #45 · Pharmacology › Pharmacokinetics · 25 Dec 2025 · 9 likes Worth separating two things that post #41 runs together. Something worth flagging about Half-life: the strongest-sounding claims in this thread are the ones with no…
Prescription requirements and telehealth models Replied, post #81 · Sourcing › Regulatory · 21 Dec 2025 · 17 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
Request: export my own posts — one year on Replied, post #24 · Meta › Feature requests · 19 Dec 2025 · 6 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site. Written quickly, so…
Early satiety becoming a problem rather than a benefit Replied, post #16 · Practice › Side effects · 15 Dec 2025 · 0 likes A note on scope: what I am saying about early satiety applies to the case in the first post and I would not extend it further without checking.
Tracking that stops updating and then resumes — the long version Replied, post #47 · Sourcing › Logistics · 5 Dec 2025 · 16 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. I would want a second opinion…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #27 · Access › Pricing · 1 Dec 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
Coverage in the US: a map of the usual obstacles Replied, post #16 · Regional › North America · 28 Nov 2025 · 2 likes Answering the question post #14 raises rather than the one it answers. Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is…
Second pass at: Programming during a large energy deficit Replied, post #101 · Nutrition & Training › Resistance training · 28 Nov 2025 · 17 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
The anatomy of a question that gets answered within an hour — the long version Replied, post #143 · Start Here › How to Ask · 25 Nov 2025 · 0 likes Adding the measurement that post #140 says would settle it. Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not…
Thyroid function tests during substantial weight change Replied, post #143 · Clinical › Bloodwork · 21 Nov 2025 · 0 likes Post #141 and I disagree about the size of the effect, not about the direction. Add biological variation and analytical imprecision to that base rate and the…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #51 · Compounds › Semaglutide · 20 Nov 2025 · 4 likes Post #48 is the version of this I will quote in future. One addition. The version of semaglutide half-life that circulates here is a simplification of a simplification.…
Pen dose counters: what a click does and does not guarantee Replied, post #91 · Devices › Pens & autoinjectors · 18 Nov 2025 · 2 likes Where I part company with post #87, and it is a narrow parting. Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to…
[2026 update] What steady state means for the decision to escalate Replied, post #83 · Practice › Dosing & titration · 13 Nov 2025 · 10 likes Helpful, and easy to find again, which is half of what a good reply is.
Reading SURMOUNT-1 without the press release Replied, post #53 · Compounds › Tirzepatide · 2 Nov 2025 · 0 likes Post #49 describes the usual case. This is about the unusual one. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #95 · Devices › Cold chain · 26 Oct 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Waist circumference technique and its repeatability Replied, post #10 · Outcomes › Progress reports · 25 Oct 2025 · 16 likes Post #7 answers the question as asked. The question underneath it is different. I have three months of notes on waist circumference technique and the honest summary is…
Insurance and replacement policies, compared — the long version Replied, post #29 · Sourcing › Logistics · 21 Oct 2025 · 30 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. That is all the detail I…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #53 · Pharmacology › Receptor biology · 16 Oct 2025 · 6 likes Post #51 answers the question as asked. The question underneath it is different. Central versus peripheral action: GLP-1 agonism works through both central nervous…
What a purity-only report leaves out Replied, post #38 · Sourcing › Independent verification · 7 Oct 2025 · 9 likes Building on post #35 rather than restating it. Reading back through the purity-only threads from last year, the same three questions come up every time and only one of…
What pooling buys you and what it destroys Replied, post #33 · Evidence › Meta-analyses · 1 Oct 2025 · 19 likes Taking post #30 at face value and following it one step further. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #59 · Compounds › Other compounds · 30 Sep 2025 · 11 likes The practical version of catalogue breadth is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
A preprint whose numbers changed substantially at publication Replied, post #59 · Evidence › Preprints · 19 Sep 2025 · 13 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it. One…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #46 · Analytics › Method validation · 12 Sep 2025 · 1 like The bit of LOD and LOQ that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
Reading SURMOUNT-1 without the press release Replied, post #6 · Compounds › Tirzepatide · 10 Sep 2025 · 0 likes Answering the question post #2 raises rather than the one it answers. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #92 · Data & Tools › Datasets · 9 Sep 2025 · 8 likes Where I part company with post #91, and it is a narrow parting. Two questions I would want answered before drawing anything from the Aggregated purity results across…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #71 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes Narrowing post #70, because the general version has more than one answer. Version the file rather than editing in place. A dataset that changes silently under an…
Travel coolers and how long they really hold Replied, post #82 · Devices › Cold chain · 8 Aug 2025 · 3 likes Where I part company with post #80, and it is a narrow parting. Adding a reference point for travel coolers. Mine is a single case, collected without controls, and I am…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #101 · Compounds › Tirzepatide · 6 Aug 2025 · 23 likes Post #98 is right about the mechanism and I think understates the practical bit. I have been on both sides of the GIP component of tirzepatide argument in this category…
How to research a compound with no human data without deceiving yourself Replied, post #83 · Compounds › Other compounds · 3 Aug 2025 · 0 likes What I would tell a new member reading about research a compound for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #67 · Sourcing › Regulatory · 2 Aug 2025 · 2 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. Scoping that to what…
When a preprint is the best available evidence and we say so Replied, post #12 · Evidence › Preprints · 31 Jul 2025 · 1 like How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
System suitability injections: if they failed, the run did not happen Replied, post #18 · Analytics › HPLC & UHPLC · 29 Jul 2025 · 27 likes Taking post #17 at face value and following it one step further. A request rather than an answer: could whoever has the primary source for system suitability injections…
Insomnia at a dose step: reported experiences Started this topic · Wellbeing › Sleep · 16 Jul 2025 · 4 likes On the subject in the title: Insomnia at a dose step: reported experiences Working notes rather than a conclusion. A sleep question with what I actually recorded rather…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #86 · Compounds › Tirzepatide · 12 Jul 2025 · 1 like Narrowing post #85, because the general version has more than one answer. Comparisons between the tirzepatide and semaglutide programmes across trials rather than…
Repeatability versus intermediate precision Replied, post #133 · Analytics › Method validation · 3 Jul 2025 · 10 likes Repeatability versus intermediate precision is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in…
EU-wide position versus national implementation Replied, post #15 · Regional › European Union · 3 Jul 2025 · 19 likes Date every claim. Positions in this subcategory have moved repeatedly and the archive keeps posts permanently. This is the version I would want a new member to read…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #43 · Compounds › Repair & healing peptides · 18 Jun 2025 · 0 likes I read post #39 twice before replying, because I had assumed the opposite. The pentadecapeptide sequence is short and stable enough to survive conditions that would…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #85 · Practice › Reconstitution · 13 Jun 2025 · 30 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I have left…
"Should I double up?" — answered once, at length, calmly Replied, post #2 · Practice › Administration · 11 Jun 2025 · 1 like Understood, and I withdraw the assumption I opened with.
Half-life, steady state, and accumulation worked through Replied, post #22 · Pharmacology › Pharmacokinetics · 25 May 2025 · 28 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
A claim built entirely on a subgroup analysis Replied, post #54 · Evidence › Study critique · 25 May 2025 · 3 likes On claim built I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #22 · Analytics › Mass spectrometry · 23 May 2025 · 4 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #33 · Compounds › Oral incretins · 17 May 2025 · 0 likes Post #31 describes the usual case. This is about the unusual one. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial.…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #94 · Sourcing › Independent verification · 14 May 2025 · 23 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
A report I filed that turned out to be wrong, and the correction Replied, post #46 · Sourcing › Vendor reports · 9 May 2025 · 16 likes Narrowing post #43, because the general version has more than one answer. The cost of a submission is worth stating. It is the main reason people do not do this and…
A supplier that answers analytical questions with restated claims Replied, post #65 · Sourcing › Red flags · 27 Apr 2025 · 0 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
Reading an MS report that only gives you a single number Replied, post #54 · Analytics › Mass spectrometry · 16 Apr 2025 · 0 likes Picking up post #51: that is the part I would want checked first. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
When "no data" is the complete and final answer Replied, post #136 · Compounds › Other compounds · 2 Apr 2025 · 1 like PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #44 · Analytics › Mass spectrometry · 24 Mar 2025 · 29 likes Adding the measurement that post #43 says would settle it. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #9 · Evidence › Journal club · 23 Mar 2025 · 2 likes Post #6 is the version of this I will quote in future. One addition. The figures usually contain the finding and the text usually contains the interpretation.…
Counter-ion form: the field almost nobody reports — one year on Replied, post #90 · Analytics › COA interpretation · 16 Mar 2025 · 22 likes A definition problem is doing most of the work in this Counter-ion form discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #134 · Sourcing › Regulatory · 5 Mar 2025 · 10 likes Confirming post #133 from a second method, which matters more than confirming it from a second person. Contradicting a claim in this subcategory is most useful when it…
UK access routes, dated and sourced — a second dataset Replied, post #45 · Regional › UK & Ireland · 2 Mar 2025 · 15 likes Cross-border movement between the two jurisdictions is not the same as domestic movement within either, and the rules are published rather than inferred. That is the…
Reading an MS report that only gives you a single number Replied, post #18 · Analytics › Mass spectrometry · 27 Feb 2025 · 27 likes Electrospray on a peptide of this size gives a multiply charged series rather than a single ion. Seeing only one charge state usually means the deconvolution has…
Validating a method you did not develop — does this still hold? Replied, post #24 · Analytics › Method validation · 19 Feb 2025 · 0 likes Picking up post #21: that is the part I would want checked first. Specificity: the method can distinguish the intended compound from related impurities and degradation…
Distinguishing a deletion sequence by mass alone Replied, post #99 · Analytics › Mass spectrometry · 17 Feb 2025 · 16 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
What we do not know about retatrutide, listed explicitly Replied, post #84 · Compounds › Retatrutide · 5 Feb 2025 · 18 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Protein density versus volume when you cannot eat much Replied, post #46 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 4 likes Liquid sources are tolerated better than solid ones by many people here, and that is a practical observation rather than a nutritional principle. I checked the source…
Recovery when intake is low: what to cut first Replied, post #66 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes Recovery is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #2 · Clinical › Bloodwork · 8 Jan 2025 · 24 likes Narrowing the opening post, because the general version has more than one answer. Glycaemic markers integrate over different periods. A point glucose and a longer-term…
Levothyroxine timing: a real interaction with a simple fix Replied, post #19 · Practice › Interactions · 3 Jan 2025 · 0 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
A certificate whose chromatogram axes do not match its stated method Replied, post #2 · Sourcing › Red flags · 1 Jan 2025 · 17 likes Worth separating two things that the opening post runs together. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #19 · Evidence › Journal club · 28 Dec 2024 · 0 likes The claim about SUSTAIN 6 upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #2 · Clinical › Bloodwork · 27 Dec 2024 · 15 likes I have been on both sides of the Lipid changes during rapid weight argument in this category within eighteen months, which should tell you how strong the evidence for…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #10 · Evidence › Meta-analyses · 25 Dec 2024 · 20 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #78 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
A vial that will not fully dissolve: what to check and in what order Replied, post #8 · marked as the solution · Practice › Reconstitution · 21 Dec 2024 · 9 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #78 · Access › Insurance & coverage · 20 Dec 2024 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #120 · Practice › Dosing & titration · 6 Dec 2024 · 31 likes Post #117 is the version of this I will quote in future. One addition. I would be cautious about generalising from the four-week escalation interval example above. It…
SURPASS-2 and the comparator dose question that will not go away Replied, post #68 · Compounds › Tirzepatide · 30 Nov 2024 · 2 likes A methods point on SURPASS-2 rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #50 · Meta › Wiki maintenance · 28 Nov 2024 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Fixed versus detachable needles: the trade-offs Replied, post #20 · Devices › Syringes & needles · 26 Nov 2024 · 0 likes Coring the stopper is a real phenomenon with repeated entries at the same point and blunt needles. Varying the entry point slightly and using a fresh needle prevents…
EMA product information as a primary source — does this still hold? Replied, post #22 · Regional › European Union · 15 Nov 2024 · 0 likes A request rather than an answer: could whoever has the primary source for EMA product information post it? I have seen the claim three times this month and each version…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #56 · Compounds › Repair & healing peptides · 14 Nov 2024 · 10 likes That is clearer than the version I had in my head. Thank you.
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #26 · Sourcing › Regulatory · 11 Nov 2024 · 22 likes Adding the measurement that post #24 says would settle it. What I can speak to on Research-use-only labelling is narrow, so I will keep it narrow rather than…
Time to steady state after a dose increase Replied, post #137 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #23 · Clinical › Prescriber conversations · 1 Nov 2024 · 10 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #13 · Sourcing › Regulatory · 25 Oct 2024 · 1 like Fair, and the limits you put on it are the part I will remember.
Promotion criteria, and the one that stops most nominations Replied, post #67 · Documentation › Doc review · 22 Sep 2024 · 27 likes Everything in post #63 holds. The case it does not cover is the one I have. Where I would push back on the promotion criteria consensus is the confidence, not the…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #18 · Clinical › Bloodwork · 9 Sep 2024 · 1 like On bring a laboratory, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
Micronutrient status when intake falls substantially — a second dataset Started this topic · Clinical › Bloodwork · 29 Jul 2024 · 0 likes Micronutrient status when intake falls substantially — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #86 · Practice › Dosing & titration · 9 Jul 2024 · 6 likes That matches what I have seen, for whatever a single anecdote is worth.